Content area

|
|

Farmakologisk behandling af gammahydroxybutyratabstinenssyndromet

Forfatter(e)
Niels August Willer Strand1, Tonny Studsgaard Petersen1, Lars Martin Nielsen2 & Søren Bøgevig1 1) Klinisk Farmakologisk Afdeling, Bispebjerg og Frederiksberg Hospital 2) Psykiatrisk Center København, Region Hovedstadens Psykiatri Ugeskr Læger 2017;179:V03170240
Reference: 
Ugeskr Læger 2017;179:V03170240
Blad nummer: 
Sidetal: 
2-8
Treatment of gamma-hydroxybutyrate withdrawal
Gamma-hydroxybutyrate (GHB) is a drug of abuse, for which physical addiction develops quickly. GHB withdrawal can develop into a life-threatening condition and has previously been treated mainly with benzodiazepines. These have not always proven effective, leading to long hospitalizations in intensive care units. Based on successful Dutch treatment results for using GHB to treat GHB withdrawal symptoms, we propose to implement a similar method in Denmark. The method requires an interdisciplinary effort for which The Danish Poison Information Centre should be consulted for expertise.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Anders Heissel | 18/09
2 kommentarer
af Alice Kunkel | 17/09
7 kommentarer
af Jørn Rosborg | 17/09
1 Kommentar
af Peter Christian Gøtzsche | 17/09
1 Kommentar
af Jens Ole Mathiesen | 16/09
3 kommentarer
af Annette Randløv | 16/09
2 kommentarer
af Jens Ole Mathiesen | 15/09
4 kommentarer
af Jens Ole Mathiesen | 14/09
4 kommentarer
af Steffen Thirstrup | 11/09
4 kommentarer
af Jane Skjøth-Rasmussen | 11/09
8 kommentarer